JACOBS LEVY EQUITY MANAGEMENT, INC - AGIOS PHARMACEUTICALS INC ownership

AGIOS PHARMACEUTICALS INC's ticker is AGIO and the CUSIP is 00847X104. A total of 162 filers reported holding AGIOS PHARMACEUTICALS INC in Q4 2022. The put-call ratio across all filers is 0.75 and the average weighting 0.1%.

Quarter-by-quarter ownership
JACOBS LEVY EQUITY MANAGEMENT, INC ownership history of AGIOS PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2023$4,095,384
-71.0%
144,611
-76.5%
0.02%
-72.4%
Q1 2023$14,115,823
+7.2%
614,533
+31.1%
0.09%
-2.2%
Q4 2022$13,162,388
-4.4%
468,746
-3.7%
0.09%
-18.3%
Q3 2022$13,765,000
+56.4%
486,726
+22.6%
0.11%
+60.3%
Q2 2022$8,802,000
-35.1%
397,015
-14.8%
0.07%
-25.3%
Q1 2022$13,561,000
+33.9%
465,852
+51.2%
0.09%
+33.8%
Q4 2021$10,125,000
-27.5%
308,041
+1.8%
0.07%
-27.7%
Q3 2021$13,963,000
+16.2%
302,547
+38.8%
0.09%
+16.0%
Q2 2021$12,015,000
+14.5%
218,022
+7.3%
0.08%0.0%
Q1 2021$10,497,000
+107.8%
203,276
+74.4%
0.08%
+84.1%
Q4 2020$5,052,000
+5.9%
116,586
-14.5%
0.04%
-10.2%
Q3 2020$4,770,000
+101.8%
136,287
+208.4%
0.05%
+88.5%
Q2 2020$2,364,000
+166.8%
44,197
+185.1%
0.03%
+62.5%
Q4 2017$886,000
-78.6%
15,500
-80.3%
0.02%
-78.4%
Q3 2016$4,148,000
+198.4%
78,537
+136.6%
0.07%
+155.2%
Q2 2016$1,390,00033,1900.03%
Other shareholders
AGIOS PHARMACEUTICALS INC shareholders Q4 2022
NameSharesValueWeighting ↓
Flagship Ventures 2007 General Partner LLC 1,930,369$118,428,00083.56%
Third Rock Ventures, LLC 3,070,090$188,350,00021.97%
Opaleye Management Inc. 113,500$6,963,225,0005.43%
BB BIOTECH AG 1,890,521$115,983,0004.72%
Eventide Asset Management 431,600$26,479,0003.70%
Atika Capital Management LLC 54,000$3,313,0002.55%
Cormorant Asset Management, LP 100,000$6,135,0001.26%
BRIDGER MANAGEMENT, LLC 220,099$13,503,0000.92%
Ghost Tree Capital, LLC 20,000$1,227,0000.67%
HAMILTON LANE ADVISORS LLC 27,544$1,690,0000.55%
View complete list of AGIOS PHARMACEUTICALS INC shareholders